A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care

NCT01907269 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2684

Last updated 2018-06-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to conduct a randomized trial of a tailored intervention designed to provide personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and digital video discs (DVDs). The content will be uniquely tailored to each person based on barriers to care, age and race/ethnicity. We will conduct a controlled, cluster-randomized trial of this intervention to determine differences in post-intervention rates of osteoporosis care between two randomization arms.

We hypothesize that participants randomized to the intervention arm, compared to those randomized to a control arm, will receive more osteoporosis care at 6 months post-intervention, as evidenced by higher rates of: (H1) Prescription osteoporosis therapies, (H2) Non-prescription therapy with calcium and vitamin D, and (H3) Bone mineral density (BMD) testing.

Conditions

Interventions

BEHAVIORAL

Video-based Intervention

Video clips delivered by DVD and Internet

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH
  • University of Massachusetts, Worcester

    collaborator OTHER
  • Helen Hayes Hospital

    collaborator OTHER
  • Kaiser Permanente

    collaborator OTHER
  • Cedars-Sinai Medical Center

    collaborator OTHER
  • University of Pittsburgh

    collaborator OTHER
  • University of Cincinnati

    collaborator OTHER
  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Kenneth G Saag, MD, MSc · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-10-31
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01907269 on ClinicalTrials.gov